Like other drugs in the fluoroquinolone class,<unk>  contains a black box warning about the risk of tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, and exacerbation of myasthenia gravis. The label also warns against the risk of hypersensitivity reactions and Clostridium difficile-associated diarrhea. Adverse effects occurring in more than 2% of clinical trial subjects included nausea, diarrhea, headache, elevated transaminases, and vomiting.
Delafloxacin
Merafloxacin
Azithromycin
Gemifloxacin
Pefloxacin
Telithromycin
Dirithromycin
Roxithromycin